
    
      Patients with verified diagnosis Hodgkin's lymphoma or non-Hodgkin's lymphoma will undergo
      peripheral blood stem cell mobilisation and collection (chemotherapy + G-CSF or
      G-CSF+Plerixafor).

      After that high-dose chemotherapy will be performed according to protocols ICE and BEAM
      (standard scheme).

      Patient will receive bone marrow derived allogeneic multipotent mesenchymal stromal cells
      infusion 48 hours after last administration of cytotoxic agent . Number of cells calculated
      according to patient's body weight (1,5-2,0 mln of cells/kg), time of infusion - 30 minutes.
      Two hours later patient will receive autologous peripheral blood cells infusion.
    
  